October 23-25, 2024 , at the U.S. Pharmacopeia Campus, Rockville, MD HOUSTON , Aug.
14, 2024 /PRNewswire/ -- The Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community, an initiative of the American Society of Pharmacovigilance (ASP) with FDA participation , is set to host its Annual Meeting and Consensus Workshop from October 23-25, 2024 , at the U.S. Pharmacopeia Campus in Rockville, MD .
This workshop represents an important milestone in the ongoing effort to develop and harmonize standards for pharmacogenomic in vitro diagnostic and lab-developed testing, seeking to align stakeholder perspectives and accelerate the adoption of personalized medicine practices as standard of care. About STRIPE: STRIPE is a continuing forum where public and private sector members collaborate to integrate personalized medicine into standard healthcare practices. Convened by the American Society of Pharmacovigilance, STRIPE unites patients, providers, industry leaders, regulators, payers, and other key stakeholders to address complex challenges and achieve common objectives in the field of pharmacogenomics.
Workshop Dates: October 23-25, 2024 Location: US Pharmacopeia (USP) Campus, 12601 Twinbrook Pkwy, Rockville, MD Purpose: Develop consensus statements related to pharmacogenomic testing and practice Registration : Available online at www.stopadr.org/events The workshop will address stakeholder challenges in pharmacogenomics, including policy and implementatio.